A lack of blood donors and poor healthcare infrastructure inspired Temie Giwa-Tubosun to develop and deliver a life-saving app. LSIPR spoke to the founder of LifeBank.
Very few people are able to say that they have helped to shape the healthcare landscape of a country. Temie Giwa-Tubosun is one of them. So widespread has been her influence, that Facebook founder Mark Zuckerberg celebrated her achievements.
After Giwa-Tubosun learned that the biggest cause of maternal mortality in Africa was postpartum haemorrhaging—where women bleed heavily after birth—and she herself had difficulty giving birth, Giwa-Tubosun decided to take action and leave her footprint on her home nation, Nigeria.
According to the founder of LifeBank, haemorrhaging kills 26,000 women every year in Nigeria, and can also affect children under five who have malaria, accident victims and cancer patients.
Life Sciences Intellectual Property Review (LSIPR) tracks the increasing challenges for intellectual property specialists in the rapidly evolving world of life sciences. From gene patents to stem cell research, we provide the very best news and analysis.
To continue reading this article and to access 4,500+ articles, our digital magazines and special reports published for LSIPR subscribers only then you will need a subscription.
If you are already subscribed please login.
Official LSIPR subscribers include:
Allen & Overy
Arnold & Siedsma
Birch, Stewart, Kolasch & Birch LLP (BSKB)
Carpmaels & Ransford
European Patent Office
George Washington Law School
Kirkland & Ellis International LLP
Marks & Clerk
NiKang Therapeutics Inc.
Powell Gilbert LLP
Procopio, Cory, Hargreaves & Savitch LLP
The United States Patent and Trademark Office (USPTO)
World Intellectual Property Office
LSIPR 50, Temie Giwa-Tubosun, mobile app, LifeBank, developing world, blood, vaccines, rare drugs, blood donor, med tech